Neuropsychological Evaluation of Patients with Inoperable Non-Small Cell Lung Cancer Treated with Combination Chemotherapy or Radiotherapy
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 27 (3) , 241-246
- https://doi.org/10.3109/02841868809093532
Abstract
Neuropsychological tests were used to evaluate possible central nervous system dysfunction in patients treated with chemotherapy. Ninety-five patients with non-small cell lung cancer limited disease were randomized to either radiotherapy (2.8 Gy .times. 15) or combination chemotherapy with cisplatin and etoposide. In order to evaluate cognitive functions three neuropsychological tests were applied: Trail Making, Benton Visual Retention Test and Verbal Learning. Changes in the patients'' test scores before and after treatment were compared. The chemotherapy patients showed reduced performance on some of the neuropsychological tests compared to the radiotherapy group. This indicates a treatment related effect on the central nervous system, possibly caused by the combination chemotherapy.This publication has 21 references indexed in Scilit:
- A randomized study evaluating radiotherapy versus chemotheraphy in patients with inoperable non-small cell lung cancerRadiotherapy and Oncology, 1988
- Neurotoxicity in long-term survivors of small cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Ototoxicity from cis-platinum in patients with Stages III and IV previously untreated squamous cell cancer of the head and neck*American Journal of Clinical Oncology, 1985
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Pharmacology and clinical applications of cis-platinumUrology, 1985
- Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.Journal of Clinical Oncology, 1984
- Cisplatin-associated cortical blindnessGynecologic Oncology, 1981
- Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old manCancer, 1980
- Adrenergic hyperactivity and cardiac abnormality in primary disorders of sleepNeurology, 1980
- Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatmentCancer, 1979